Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Thiery

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Scientific Reports|March 7, 2017
Data-Driven Discovery of Extravasation Pathway in Circulating Tumor CellsS Yadavalli, S Jayaram, S S Manda, et al.
Histopathology|July 29, 2004
Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breastX Sastre-Garau, P Genin, A Rousseau, et al.
British Journal of Cancer|November 27, 2001
p15(INK4b) in bladder carcinomas: decreased expression in superficial tumoursM A Le Frère-Belda, D Cappellen, A Daher, et al.
Oncogene|December 22, 1999
Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancerD Ricol, D Cappellen, A El Marjou, et al.
Bulletin Du Cancer|August 29, 2006
Challenges in the stratification of breast tumors for tailored therapiesJ-P Thiery, X Sastre-Garau, B Vincent-Salomon, et al.
British Journal of Cancer|March 18, 2004
Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastasesM Karoui, C Tresallet, C Julie, et al.
The American Journal of Pathology|June 8, 2001
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumorsC Billerey, D Chopin, M H Aubriot-Lorton, et al.
Oncogene|August 30, 2001
No evidence of somatic FGFR3 mutation in various types of carcinomaM Karoui, H Hofmann-Radvanyi, U Zimmermann, et al.
Cell Death & Disease|November 9, 2013
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)R Y-J Huang, M K Wong, T Z Tan, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Scientific Reports|March 7, 2017
Data-Driven Discovery of Extravasation Pathway in Circulating Tumor CellsS Yadavalli, S Jayaram, S S Manda, et al.
Histopathology|July 29, 2004
Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breastX Sastre-Garau, P Genin, A Rousseau, et al.
British Journal of Cancer|November 27, 2001
p15(INK4b) in bladder carcinomas: decreased expression in superficial tumoursM A Le Frère-Belda, D Cappellen, A Daher, et al.
Oncogene|December 22, 1999
Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancerD Ricol, D Cappellen, A El Marjou, et al.
Bulletin Du Cancer|August 29, 2006
Challenges in the stratification of breast tumors for tailored therapiesJ-P Thiery, X Sastre-Garau, B Vincent-Salomon, et al.
British Journal of Cancer|March 18, 2004
Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastasesM Karoui, C Tresallet, C Julie, et al.
The American Journal of Pathology|June 8, 2001
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumorsC Billerey, D Chopin, M H Aubriot-Lorton, et al.
Oncogene|August 30, 2001
No evidence of somatic FGFR3 mutation in various types of carcinomaM Karoui, H Hofmann-Radvanyi, U Zimmermann, et al.
Cell Death & Disease|November 9, 2013
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)R Y-J Huang, M K Wong, T Z Tan, et al.
Pageof 20